Author

Karima Habbas

Centre National de la Recherche Scientifique

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2

Frequent Co-Authors

Boglárka ZámbóiD· 2 shared Hervé MoineiD· 2 shared Jean‐Louis MandeliD· 2 shared Andréa Geoffroy· 1 shared Arnaud DuchoniD· 1 shared Dimitri HeintziD· 1 shared Doulaye DembéléiD· 1 shared Eric FlatteriD· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersNeuroscience

Boglárka ZámbóORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

AAV-delivery of diacylglycerol kinase kappa achieves long-term rescue of Fmr1-KO mouse model deficits of fragile X syndrome

Karima Habbas, Oktay Cakil, Boglárka Zámbó, Ricardos Tabet, Fabrice Riet, Doulaye Dembélé, Jean‐Louis Mandel, Michaël Hocquemiller, Ralph Laufer, Françoise Piguet, Hervé Moine

AAV-delivered FMRP-independent DGKk corrects brain lipid homeostasis and behavioral deficits in Fmr1-KO mice.

bioRxiv · Apr 14, 2021 · PreprintNeuroscience

Pioglitazone improves deficits of Fmr1-KO mouse model of Fragile X syndrome by interfering with excessive diacylglycerol signaling

Andréa Geoffroy, Karima Habbas, Boglárka Zámbó, Laetitia Schramm, Arnaud Duchon, Eric Flatter, Laëtitia Fouillen, Julie Zumsteg, Dimitri Heintz, Jean‐Louis Mandel, Yann Hérault, Hervé Moine

This study shows pioglitazone reduces excessive diacylglycerol signaling in Fmr1-KO mice, improving behavioral deficits associated with Fragile X syndrome.

bioRxiv · Sep 22, 2020 · PreprintNeuroscience